---
title: 4T-1 Syngeneic Model - TD2 Precision Oncology
description: Explore 4T-1, a valuable murine mammary tumor cell line for breast cancer research. Study tumor growth, metastasis, and treatment interventions for improved understanding and management.
image: https://td2inc.com/hubfs/Assets/GraphsFigures/4t-1.png
---

×

 

[![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en)

![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png)

[![td2-logo](https://td2inc.com/hubfs/td2-logo.png "td2-logo")](https://td2inc.com/?hsLang=en)

![Search Site](https://td2inc.com/hubfs/Assets/Icon/search-icon-1.png)

# 4T-1 Syngeneic Model

**Synonyms:** 4T1 mammary carcinoma cell line, 4T1 breast cancer cell line

4T-1 is a well-established cancer cell line derived from a murine mammary tumor. It is widely used in breast cancer research, providing valuable insights into tumor growth, metastasis, and therapeutic interventions. The cells exhibit characteristics similar to human breast cancer, making them suitable for studying the disease. 4T-1 cells have an epithelial morphology and can form tumors when implanted in animal models. Researchers utilize 4T-1 to investigate various aspects of breast cancer, including genetic alterations, signaling pathways, immune responses, and drug sensitivity. It has been extensively employed in preclinical models to evaluate the efficacy of different treatment approaches, such as chemotherapy, targeted therapies, immunotherapy, and combination treatments. The 4T-1 cell line plays a crucial role in advancing our understanding of breast cancer and developing novel strategies for its diagnosis and treatment.

## Model Details

**Cancer Type:** Breast Cancer  
**Model Name:** 4T-1  
**Mouse Strain:** balb/c  
**Treatment Data Available:** aPD-1, Chemotherapy

## 4T-1 Growth Curves: Response to aPD-1

![4T-1 Syngeneic Model](https://td2inc.com/hubfs/Assets/GraphsFigures/4t-1.png)

Growth of orthotopic 4T-1 in balb/c mice (n=10). Response to aPD-1 dosed Q3Dx4.

### Request Additional Syngeneic Model Data

## CONTACT US

## Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.

[Get Started Now](https://td2inc.com/contact-us/?hsLang=en)

[![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/td2-logo.png?width=160&name=td2-logo.png)](https://td2inc.com/?hsLang=en)

Office  
13208 E. Shea Blvd,   
Suite 100   
Scottsdale, AZ 85259

Phone  
(602) 358-8300

Connect with us

- <https://www.linkedin.com/company/translational-drug-development/>
- <https://twitter.com/TD2_Oncology>

![td2-logo-footer](https://td2inc.com/hs-fs/hubfs/Assets/Logo/acclac-logo.png?width=139&name=acclac-logo.png)

© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)